Akari Therapeutics PLC (AKTX : NASDAQ)
Common Stock
$8.84
USD
+1.56 (21.43%)
Last updated: 2026-10-15
Follow AKTX
AKTX
Akari Therapeutics PLC
WealthAwesomePerformance
1 Day
+21.43%
1 Week
+8.73%
1 Month
-13.76%
YTD
-26.33%
Key Statistics
Market Cap
$16.64M
52W High
$33.60
52W Low
$3.02
P/E Ratio
-
50 Day MA
$9.04
200 Day MA
$9.22
Beta
1.44
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/15/2026 | $7.87 | $8.89 | $7.00 | $8.84 | $8.84 | 55,638 |
| 10/14/2026 | $8.10 | $8.10 | $7.19 | $7.28 | $7.28 | 34,875 |
| 10/13/2026 | $8.33 | $8.70 | $7.90 | $7.90 | $7.90 | 18,524 |
| 10/12/2026 | $8.70 | $9.05 | $8.34 | $8.54 | $8.54 | 112,358 |
| 10/9/2026 | $8.51 | $8.97 | $8.20 | $8.77 | $8.77 | 76,400 |
| 10/8/2026 | $8.61 | $8.73 | $8.13 | $8.13 | $8.13 | 61,877 |
| 10/7/2026 | $8.46 | $8.63 | $8.05 | $8.63 | $8.63 | 32,435 |
| 10/6/2026 | $8.96 | $8.96 | $8.13 | $8.39 | $8.39 | 19,698 |
| 10/5/2026 | $8.84 | $9.39 | $8.53 | $8.94 | $8.94 | 9,561 |
| 10/2/2026 | $9.01 | $9.14 | $8.26 | $8.72 | $8.72 | 15,300 |
Analyst Price Targets
Based on 3 analysts covering AKTX · as of Oct 5, 2026
Wall Street analysts forecast AKTX stock price to rise 188.5% over the next 12 months.
Consensus
Strong Buy4.67 / 5.00
Avg. Target
US$25.50
+188.5% Upside
Current Price
US$8.84
Last close
Analyst Breakdown (3 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AKTX's historical volatility
30-Day Vol
95.6%
Annualized
90-Day Vol
120.3%
Annualized
Trend (90d)
-43.7%
Annualized drift
90d Mean
US$7.56
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$8.39 | US$6.03 – US$11.67 |
| 60 trading days | US$7.97 | US$5.00 – US$12.70 |
| 90 trading days | US$7.56 | US$4.27 – US$13.39 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Akari Therapeutics PLC
Akari Therapeutics, Plc, an oncology company, develops antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that leads to additional cancer cell killing. The company's lead product candidate is AKTX-101, a preclinical stage trop2-targeting ADC that combines PH1 with the trop2 antibody to treat solid tumor cancer types, including lung, breast, bladder, head and neck, gastric, pancreatic, colon, prostate, and others. Its payloads include PH1 is a novel payload that is a spliceosome modulator designed to disrupt RNA splicing within cancer cells. The company also develops AKTX-102, a novel bispecific ADC that utilizes PH1 as its payload to treat various solid tumor cancers. Akari Therapeutics, Plc is headquartered in Tampa, Florida.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-12.08M
- Profit Margin
- 0.00%
- ROE (TTM)
- -140.09%
- EPS (Diluted)
- 0.00
- Book Value
- 10.62
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About AKTX.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| KNDI | Kandi Technologies Group Inc | $4.11 | +928.50% |
| ESLA | Estrella Immunopharma Inc. | $0.54 | +68.35% |
| SDST | Stardust Power Inc. | $0.04 | +55.38% |
| XLAB | Exascale Labs Holdings Inc. Class A Common Stock | $1.36 | +49.70% |
| WETO | Webus International Limited Ordinary Shares | $1.22 | +46.88% |
| RITRF | Reitar Logtech Holdings Limited | $0.02 | +40.85% |
| DRMA | Dermata Therapeutics Inc | $0.91 | +37.19% |
| LESLQ | Leslie's, Inc. | $0.03 | +35.75% |